S

S2Medical AB (publ)
STO:S2M

Watchlist Manager
S2Medical AB (publ)
STO:S2M
Watchlist
Price: 0.011 SEK 4.76% Market Closed
Market Cap: kr9.2m

Relative Value

The Relative Value of one S2M stock under the Base Case scenario is hidden SEK. Compared to the current market price of 0.011 SEK, S2Medical AB (publ) is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

S2M Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

S2M Competitors Multiples
S2Medical AB (publ) Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
S2Medical AB (publ)
STO:S2M
8.9m SEK 0.5 -9.4 -102.4 -4.8
JP
Hoya Corp
TSE:7741
8.6T JPY 9.7 41.3 25.6 30.7
CH
Alcon AG
SIX:ALC
30.4B CHF 3.8 37.4 19.6 38.1
US
Medline Inc
NASDAQ:MDLN
35.8B USD 0 0 0 0
DK
Coloplast A/S
CSE:COLO B
119.1B DKK 4.3 32.9 15.2 18.1
US
Align Technology Inc
NASDAQ:ALGN
11.8B USD 3 31.5 14.3 18.1
UK
ConvaTec Group PLC
LSE:CTEC
4.8B GBP 2.7 29.8 17.9 29.1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.8B CNY 9.4 25.8 23.2 23.2
KR
HLB Inc
KOSDAQ:028300
8.7T KRW 97.1 -35.6 -89.1 -84.3
CA
Bausch + Lomb Corp
NYSE:BLCO
6B USD 1.2 -19.5 19.5 91.8
CH
Ypsomed Holding AG
SIX:YPSN
4.3B CHF 5.4 21.9 14.2 19.2
P/E Multiple
Earnings Growth PEG
SE
S
S2Medical AB (publ)
STO:S2M
Average P/E: 31.5
Negative Multiple: -9.4
N/A N/A
JP
Hoya Corp
TSE:7741
41.3
13%
3.2
CH
Alcon AG
SIX:ALC
37.4
25%
1.5
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
32.9
22%
1.5
US
Align Technology Inc
NASDAQ:ALGN
31.5
27%
1.2
UK
ConvaTec Group PLC
LSE:CTEC
29.8
33%
0.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
25.8
9%
2.9
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -35.6 N/A N/A
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -19.5 N/A N/A
CH
Ypsomed Holding AG
SIX:YPSN
21.9
32%
0.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SE
S
S2Medical AB (publ)
STO:S2M
Average EV/EBITDA: 18.7
Negative Multiple: -102.4
N/A N/A
JP
Hoya Corp
TSE:7741
25.6
11%
2.3
CH
Alcon AG
SIX:ALC
19.6
8%
2.4
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
15.2
8%
1.9
US
Align Technology Inc
NASDAQ:ALGN
14.3
13%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
17.9
10%
1.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.2
15%
1.5
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -89.1 N/A N/A
CA
Bausch + Lomb Corp
NYSE:BLCO
19.5
21%
0.9
CH
Ypsomed Holding AG
SIX:YPSN
14.2
21%
0.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
SE
S
S2Medical AB (publ)
STO:S2M
Average EV/EBIT: 33.5
Negative Multiple: -4.8
N/A N/A
JP
Hoya Corp
TSE:7741
30.7
N/A N/A
CH
Alcon AG
SIX:ALC
38.1
23%
1.7
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
18.1
8%
2.3
US
Align Technology Inc
NASDAQ:ALGN
18.1
16%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
29.1
22%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.2
11%
2.1
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -84.3 N/A N/A
CA
Bausch + Lomb Corp
NYSE:BLCO
91.8
60%
1.5
CH
Ypsomed Holding AG
SIX:YPSN
19.2
29%
0.7